BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 6201038)

  • 1. Nature of cross-reactivity between Haemophilus influenzae types a and b and Streptococcus pneumoniae types 6A and 6B.
    Lagergård T; Branefors P
    Acta Pathol Microbiol Immunol Scand C; 1983 Dec; 91(6):371-6. PubMed ID: 6201038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative immunogenicity of group 6 pneumococcal type 6A(6) and type 6B(26) capsular polysaccharides.
    Robbins JB; Lee CJ; Rastogi SC; Schiffman G; Henrichsen J
    Infect Immun; 1979 Dec; 26(3):1116-22. PubMed ID: 43290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-reactivity of antibodies to type 6B and 6A polysaccharides of Streptococcus pneumoniae, evoked by pneumococcal conjugate vaccines, in infants.
    Väkeväinen M; Eklund C; Eskola J; Käyhty H
    J Infect Dis; 2001 Sep; 184(6):789-93. PubMed ID: 11517443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of crossreactive idiotypes by human antibodies specific for the capsular polysaccharide of Hemophilus influenzae B.
    Lucas AH
    J Clin Invest; 1988 Feb; 81(2):480-6. PubMed ID: 3257499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing an ELISA using serotype-specific antigens from selected pneumococcal strains of own selection.
    Slotved HC; Jacobsen JN; Møller HK; Krogfelt KA
    Vaccine; 2007 Mar; 25(13):2513-7. PubMed ID: 17007972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyribitol-phosphate: an antigen of four gram-positive bacteria cross-reactive with the capsular polysaccharide of haemophilus influenzae type B.
    Argaman M; Liu TY; Robbins JB
    J Immunol; 1974 Feb; 112(2):649-55. PubMed ID: 4205205
    [No Abstract]   [Full Text] [Related]  

  • 7. An Escherichia coli antigen cross-reactive with the capsular polysaccharide of Haemophilus influenzae type b: occurrence among known serotypes, and immunochemical and biologic properties of E. coli antisera toward H. influenzae type b.
    Schneerson R; Bradshaw M; Whisnant JK; Myerowitz RL; Parke JC; Robbins JB
    J Immunol; 1972 Jun; 108(6):1551-62. PubMed ID: 4624175
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthetic 6B di-, tri-, and tetrasaccharide-protein conjugates contain pneumococcal type 6A and 6B common and 6B-specific epitopes that elicit protective antibodies in mice.
    Jansen WT; Hogenboom S; Thijssen MJ; Kamerling JP; Vliegenthart JF; Verhoef J; Snippe H; Verheul AF
    Infect Immun; 2001 Feb; 69(2):787-93. PubMed ID: 11159969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polysaccharides of the genus Bacillus cross-reactive with the capsular polysaccharides of Diplococcus pneumoniae type 3, Haemophilus influenzae type b, and Neisseria meningitidis group A.
    Myerowitz RL; Gordon RE; Robbins JB
    Infect Immun; 1973 Dec; 8(6):896-900. PubMed ID: 4150383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoelectric focusing of human antibody to the Haemophilus influenzae b capsular polysaccharide: restricted and identical spectrotypes in adults.
    Insel RA; Kittelberger A; Anderson P
    J Immunol; 1985 Oct; 135(4):2810-6. PubMed ID: 3897378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of enzyme-linked immunosorbent assay and radioimmunoassay for determination of anti-pneumococcal polysaccharide antibodies.
    Pedersen FK; Henrichsen J; Schiffman G
    Acta Pathol Microbiol Immunol Scand C; 1983 Aug; 91(4):251-5. PubMed ID: 6356780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical differences between pneumococcal polysaccharide enzyme-linked immunosorbent assays with and without 22F inhibition at low antibody concentrations in pediatric sera.
    Henckaerts I; Goldblatt D; Ashton L; Poolman J
    Clin Vaccine Immunol; 2006 Mar; 13(3):356-60. PubMed ID: 16522777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and structure characterization of the active component in the pneumococcal 22F polysaccharide capsule used for adsorption in pneumococcal enzyme-linked immunosorbent assays.
    Skovsted IC; Kerrn MB; Sonne-Hansen J; Sauer LE; Nielsen AK; Konradsen HB; Petersen BO; Nyberg NT; Duus JØ
    Vaccine; 2007 Aug; 25(35):6490-500. PubMed ID: 17655983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum antibodies after vaccination with Haemophilus influenzae type b capsular polysaccharide and responses to reimmunization: no evidence of immunologic tolerance or memory.
    Käyhty H; Karanko V; Peltola H; Mäkelä PH
    Pediatrics; 1984 Nov; 74(5):857-65. PubMed ID: 6387614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunity to cross-reactive serotypes induced by pneumococcal conjugate vaccines in infants.
    Yu X; Gray B; Chang S; Ward JI; Edwards KM; Nahm MH
    J Infect Dis; 1999 Nov; 180(5):1569-76. PubMed ID: 10515817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunochemical relations between pneumococcal group 19 and Klebsiella capsular polysaccharides.
    Lee CJ; Koizumi K
    J Immunol; 1981 Oct; 127(4):1619-23. PubMed ID: 6792279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide mimics of two pneumococcal capsular polysaccharide serotypes (6B and 9V) protect mice from a lethal challenge with Streptococcus pneumoniae.
    Smith CM; Lo Passo C; Scuderi A; Kolberg J; Baxendale H; Goldblatt D; Oggioni MR; Felici F; Andrew PW
    Eur J Immunol; 2009 Jun; 39(6):1527-35. PubMed ID: 19499518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Avidity, potency, and cross-reactivity of monoclonal antibodies to pneumococcal capsular polysaccharide serotype 6B.
    Sun Y; Hwang Yi; Nahm MH
    Infect Immun; 2001 Jan; 69(1):336-44. PubMed ID: 11119522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunological principles of polysaccharide-protein conjugate vaccination].
    Meyer M; Gahr M
    Monatsschr Kinderheilkd; 1993 Oct; 141(10):770-6; quiz 777, 812-3. PubMed ID: 7505396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of early and late vaccination with Haemophilus influenzae type b conjugate and pneumococcal polysaccharide vaccines after allogeneic BMT.
    Parkkali T; Käyhty H; Ruutu T; Volin L; Eskola J; Ruutu P
    Bone Marrow Transplant; 1996 Nov; 18(5):961-7. PubMed ID: 8932852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.